Increased risk of acute myeloid leukaemia after treatment for breast cancer

Breast

Volumn 15, Issue 5, 2006, Pages 614-619

  Renella, R ^a   Verkooijen, H M ^a   Fioretta, G ^a   Vlastos, G ^b   Kurtz, J ^b   Sappino, A P ^b   Schafer P ^b   Neyroud Caspar, I ^a   Bouchardy, C ^a  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute myeloid leukaemia; Breast cancer; Cancer registry; Chemotherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; TAMOXIFEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BREAST CANCER; CALCULATION; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENDER BIAS; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION;

EID: 33749452243     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.11.007     Document Type: Article

References (15)

1. Blanks R.G., Moss S.M., McGahan C.E., Quinn M.J., and Babb P.J. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 321 (2000) 665-669
2. Curtis R.E., Boice Jr. J.D., Stovall M., et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326 (1992) 1745-1751
3. Rubino C., De Vathaire F., Diallo I., Shamsaldin A., and Le M.G. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 61 (2000) 183-195
4. Smith R.E., Bryant J., DeCillis A., and Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 21 (2003) 1195-1204
5. Bernard-Marty C., Mano M., Paesmans M., et al. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 14 (2003) 693-698
6. Kaplan H.G., Malmgren J.A., and Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer 101 (2004) 1529-1536
7. Chaplain G., Milan C., Sgro C., Carli P.M., and Bonithon-Kopp C. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 18 (2000) 2836-2842
8. Bouchardy C, Switzerland, Geneva. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents, vol. VII. Lyon: International Agency for Research on Cancer; 1997, p. 666-9.
9. World Health Organization (WHO), editor. ICD-O International classification of diseases for oncology, 1st ed. Geneva: World Health Organization; 1976.
10. Coleman MP, Hermon C, Douglas A. Person-Years (PYRS). A Fortran program for cohort study analysis. IARC Internal Report 89/006, International Agency for Research on Cancer (IARC), Lyon, 1989.
11. Andersen M.K., Christiansen D.H., Jensen B.A., Ernst P., Hauge G., and Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 114 (2001) 539-543
12. Carli P.M., Sgro C., Parchin-Geneste N., et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 14 (2000) 1014-1017
13. Philpott N.J., Bevan D.H., and Gordon-Smith E.C. Secondary leukaemia after MMM combined modality therapy for breast carcinoma. Lancet 341 (1993) 1289
14. Cremin P., Flattery M., McCann S.R., and Daly P.A. Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin. Ann Oncol 7 (1996) 745-746
15. Saso R., Kulkarni S., Mitchell P., et al. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 83 (2000) 91-94